Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity - Thailand PR News

 - [Banking](https://thailandbusinessnews.net/category/banking/)
- [Companies](https://thailandbusinessnews.net/category/companies/)
- [Economy](https://thailandbusinessnews.net/category/economy/)
- [Press Releases](https://thailandbusinessnews.net/category/press-release/)
    - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/)
- [Tech](https://thailandbusinessnews.net/category/tech/)
- [Tourism](https://thailandbusinessnews.net/category/tourism/)

    - [Press Release](https://thailandbusinessnews.net/category/press-release/)

# Ascletis Announces First Participants Dosed in a U.S. Clinical Study Combining Adipose-Targeted, Once-Monthly Injectable Small Molecule THRβ Agonist, ASC47, and Semaglutide for the Treatment of Obesity

   #####  Up next

  ![BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025](https://i0.wp.com/r2.thailandbusinessnews.net/2025/05/BioFlag_Showcases_Innovative_Probiotic_Solutions_at_Vitafoods_Europe_2025.jpg?resize=200%2C110&ssl=1 "BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025")

 [](https://thailandbusinessnews.net/press-release/bioflag-showcases-innovative-probiotic-solutions-at-vitafoods-europe-2025/)

 ###### [BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025](https://thailandbusinessnews.net/press-release/bioflag-showcases-innovative-probiotic-solutions-at-vitafoods-europe-2025/)

  Published on 20 May 2025 #####  Author

#####   [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/)

  ##### Tags

- [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/)

– The combination study is designed to evaluate the safety and preliminary efficacy of a single-dose of ultra-long-acting subcutaneously administered ASC47 in combination with four doses of semaglutide (0.5 mg, once-weekly) in participants with obesity.

– Asan adipose-targeted, muscle-preserving weight loss drug candidate for the treatment of obesity, ASC47 monotherapy demonstrated a half-life of up to 40 days in a Phase Ib study in participants with obesity.

– In a head-to-head diet-induced obese (DIO) mouse model, low dose ASC47 in combination with semaglutide demonstrated a 56.7% greater reduction in body weight with muscle preservation compared to semaglutide monotherapy.

– Topline data from the combination clinical study are expected in the fourth quarter of 2025.

 HONG KONG, May 20, 2025 /PRNewswire/ — Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces that the first participants have been dosed in the randomized, double-blind, placebo-controlled study (ASC47-103 study) evaluating the safety and preliminary efficacy of single-dose, ultra-long-acting subcutaneously (SQ) administered ASC47 in combination with semaglutide in participants with obesity who do not have Type 2 diabetes. The ASC47-103 study, conducted in the U.S., consists of three cohorts with single ascending doses (10 mg, 30 mg and 60 mg) of ASC47 or volume-matched placebo. Participants in each cohort will also receive four doses of semaglutide (0.5 mg, once weekly) ([NCT06972992](https://clinicaltrials.gov/study/NCT06972992?term=ASC47&rank=2)).

ASC47 is an adipose-targeted, ultra-long-acting SQ injected thyroid hormone receptor beta (THRβ) selective small molecule agonist, discovered and developed in-house at Ascletis. ASC47 possesses unique and differentiated properties to enable adipose targeting, resulting in dose-dependent high drug concentrations in the adipose tissue. ASC47 monotherapy demonstrated a half-life of up to 40 days in a Phase Ib study in participants with obesity. In a head-to-head diet-induced obese (DIO) mouse model, low dose ASC47 in combination with semaglutide demonstrated a 56.7% greater reduction in body weight with muscle preservation compared to semaglutide monotherapy.

Topline data from the ASC47-103 study are expected in the fourth quarter of 2025.

"To our knowledge, this is the first clinical study combining THRβ targeting mechanism and an incretin drug for obesity," said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis, "We believe data from this combination study will help us design our once-monthly combination study of ASC47 and ASC30 (GLP-1R agonist), both of which have demonstrated a long half-life of 40 days and 36 days, respectively, in participants with obesity."

 About ASC47-103 Study

The ASC47-103 study, conducted in the U.S., is a randomized, double-blind, placebo-controlled clinical study designed to evaluate the safety and preliminary efficacy of single-dose, ultra-long-acting subcutaneously (SQ) administered ASC47 in combination with semaglutide in participants with obesity (body mass index ≥ 30 kg/m2). The ASC47-103 study consists of three cohorts: Cohort 1 participants will receive a single dose of 10 mg ASC47, or volume-matched placebo via SQ injection, and four doses of semaglutide (0.5 mg, once-weekly) via SQ injection. Cohort 2 participants will receive a single dose of 30 mg ASC47, or volume-matched placebo via SQ injection, and four doses of semaglutide (0.5 mg, once-weekly) via SQ injection. Cohort 3 participants will receive a single dose of 60 mg ASC47, or volume-matched placebo via SQ injection, and four doses of semaglutide (0.5 mg, once-weekly) via SQ injection.

 About Ascletis Pharma Inc.

Ascletis is an innovative R&amp;D driven biotech listed on the Hong Kong Stock Exchange (1672.HK), covering the entire value chain from discovery and development to GMP manufacturing. Led by a management team with deep expertise and a proven track record, Ascletis is focused on metabolic diseases by addressing unmet medical needs from a global perspective. Ascletis has multiple clinical stage drug candidates in its metabolic disease pipeline.

For more information, please visit [www.ascletis.com](http://www.ascletis.com/).

Contact：

Peter VozzoICR Healthcare443-231-0505 (U.S.)<Peter.vozzo@icrhealthcare.com>

Ascletis Pharma Inc. PR and IR teams+86-181-0650-9129 (China)<pr@ascletis.com><ir@ascletis.com>

[Source link ](https://www.prnasia.com/story/archive/4692026_AE92026_0?rand=89749)

```
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
```

  #####  You May Also Like

  [](https://thailandbusinessnews.net/press-release/nabr-comment-on-iucn-determination/) ![NABR Comment on IUCN Determination](https://i0.wp.com/r2.thailandbusinessnews.net/2025/02/NABR_Logo_1.jpg?resize=260%2C140&ssl=1 "NABR Comment on IUCN Determination")

- [Press Release](https://thailandbusinessnews.net/category/press-release/)

 ## NABR Comment on IUCN Determination

  WASHINGTON, Oct. 14, 2025 /PRNewswire/ — The International Union for Conservation of…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- October 14, 2025

   [](https://thailandbusinessnews.net/press-release/papablic-launches-safeguardplus-baby-bottle-washer-the-worlds-first-with-built-in-water-purification-to-remove-lead-and-soften-water/) ![Papablic Launches SafeguardPlus™ Baby Bottle Washer, the World's First with built-in Water Purification to Remove Lead and Soften Water](https://i0.wp.com/mma.prnasia.com/media2/2868969/1.jpg?resize=260%2C140&ssl=1 "Papablic Launches SafeguardPlus™ Baby Bottle Washer, the World's First with built-in Water Purification to Remove Lead and Soften Water")

- [Press Release](https://thailandbusinessnews.net/category/press-release/)

 ## Papablic Launches SafeguardPlus™ Baby Bottle Washer, the World's First with built-in Water Purification to Remove Lead and Soften Water

  NEW YORK, Jan. 29, 2026 /PRNewswire/ — Papablic, a brand trusted by over…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- January 29, 2026

   [](https://thailandbusinessnews.net/press-release/turnitin-delivers-turnitin-clarity-to-bring-transparency-and-responsible-ai-to-the-writing-process-supporting-academic-integrity-in-education/) ## Turnitin Delivers Turnitin Clarity to Bring Transparency and Responsible AI to the Writing Process, Supporting Academic Integrity in Education

  As AI Reshapes How Students Learn and Write, The Next Generation of…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- July 15, 2025

 ##### Most Read

- [![Manulife appoints Sarah Chapman as Global Chief Marketing & Customer Experience Officer, joining Executive Leadership Team](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/manulife-appoints-sarah-chapman-as-global-chief-marketing-customer-experience-officer-joining-executive-leadership-team/ "Manulife appoints Sarah Chapman as Global Chief Marketing & Customer Experience Officer, joining Executive Leadership Team") [Manulife appoints Sarah Chapman as Global Chief Marketing &amp; Customer Experience Officer, joining Executive Leadership Team](https://thailandbusinessnews.net/press-release/manulife-appoints-sarah-chapman-as-global-chief-marketing-customer-experience-officer-joining-executive-leadership-team/ "Manulife appoints Sarah Chapman as Global Chief Marketing & Customer Experience Officer, joining Executive Leadership Team")
- [![ReThink HK 2026 Opens at HKCEC, Bringing Business, Government and NGOs Together to Accelerate Climate Action](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/rethink-hk-2026-opens-at-hkcec-bringing-business-government-and-ngos-together-to-accelerate-climate-action/ "ReThink HK 2026 Opens at HKCEC, Bringing Business, Government and NGOs Together to Accelerate Climate Action") [ReThink HK 2026 Opens at HKCEC, Bringing Business, Government and NGOs Together to Accelerate Climate Action](https://thailandbusinessnews.net/press-release/rethink-hk-2026-opens-at-hkcec-bringing-business-government-and-ngos-together-to-accelerate-climate-action/ "ReThink HK 2026 Opens at HKCEC, Bringing Business, Government and NGOs Together to Accelerate Climate Action")
- [![Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/fashion-summit-hk-2026-code-the-fashion-forward-at-the-hong-kong-palace-museum-global-fashion-leaders-innovators-and-local-design-talents-gather-sharing-insights-to-co-create-a-green/ "Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion") [Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion](https://thailandbusinessnews.net/press-release/fashion-summit-hk-2026-code-the-fashion-forward-at-the-hong-kong-palace-museum-global-fashion-leaders-innovators-and-local-design-talents-gather-sharing-insights-to-co-create-a-green/ "Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion")
- [![Midea Unveils VitaBreeze: An AC Beyond Cooling and Heating](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/midea-unveils-vitabreeze-an-ac-beyond-cooling-and-heating/ "Midea Unveils VitaBreeze: An AC Beyond Cooling and Heating") [Midea Unveils VitaBreeze: An AC Beyond Cooling and Heating](https://thailandbusinessnews.net/press-release/midea-unveils-vitabreeze-an-ac-beyond-cooling-and-heating/ "Midea Unveils VitaBreeze: An AC Beyond Cooling and Heating")
- [![Alpha Ladder WealthX Among Asia's First to Bring xStocks US Tokenised Equities to Institutional and Accredited Investors](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/alpha-ladder-wealthx-among-asias-first-to-bring-xstocks-us-tokenised-equities-to-institutional-and-accredited-investors/ "Alpha Ladder WealthX Among Asia's First to Bring xStocks US Tokenised Equities to Institutional and Accredited Investors") [Alpha Ladder WealthX Among Asia's First to Bring xStocks US Tokenised Equities to Institutional and Accredited Investors](https://thailandbusinessnews.net/press-release/alpha-ladder-wealthx-among-asias-first-to-bring-xstocks-us-tokenised-equities-to-institutional-and-accredited-investors/ "Alpha Ladder WealthX Among Asia's First to Bring xStocks US Tokenised Equities to Institutional and Accredited Investors")
- [![SJourney Enters a New Chapter with Arsenale's 33% Strategic Investment](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/sjourney-enters-a-new-chapter-with-arsenales-33-strategic-investment/ "SJourney Enters a New Chapter with Arsenale's 33% Strategic Investment") [SJourney Enters a New Chapter with Arsenale's 33% Strategic Investment](https://thailandbusinessnews.net/press-release/sjourney-enters-a-new-chapter-with-arsenales-33-strategic-investment/ "SJourney Enters a New Chapter with Arsenale's 33% Strategic Investment")

##### Subscribe via Email

 Enter your email address to subscribe and receive notifications of new posts by email.

  Email Address

       Subscribe

  [](https://thailandbusinessnews.net/press-release/amid-a-changing-global-landscape-countries-seek-investment-opportunities-at-cifit/) ![Amid a Changing Global Landscape, Countries Seek Investment Opportunities at CIFIT](https://i0.wp.com/mmx.prnasia.com/media/MS1986889/20260912013516EDT_image_1.jpg?resize=260%2C140&ssl=1 "Amid a Changing Global Landscape, Countries Seek Investment Opportunities at CIFIT")

 ## Amid a Changing Global Landscape, Countries Seek Investment Opportunities at CIFIT

  Click to learn more: https://youtube.com/shorts/gZ3xQzfZhoo?si=hCiDYS9P0_P32ve7 …

   [](https://thailandbusinessnews.net/press-release/qivika-to-launch-smart-scope-on-kickstarter-bringing-a-professional-long-range-experience-to-day-and-night-exploration/) ![QIVIKA to Launch Smart Scope on Kickstarter, Bringing a Professional Long-Range Experience to Day-and-Night Exploration](https://i0.wp.com/mmx.prnasia.com/media/MS1986483/20260911084649EDT_image_1.jpg?resize=260%2C140&ssl=1 "QIVIKA to Launch Smart Scope on Kickstarter, Bringing a Professional Long-Range Experience to Day-and-Night Exploration")

 ## QIVIKA to Launch Smart Scope on Kickstarter, Bringing a Professional Long-Range Experience to Day-and-Night Exploration

  BERLIN and NEW YORK, Sept. 12, 2026 /PRNewswire/ — QIVIKA, a consumer…

   [](https://thailandbusinessnews.net/press-release/the-generation-essential-groups-receipt-of-nyse-letter-regarding-class-a-ordinary-shares-trading-price/) ## The Generation Essential Group's Receipt of NYSE Letter Regarding Class A Ordinary Shares Trading Price

  NEW YORK and LONDON, Sept. 12, 2026 /PRNewswire/ — The Generation Essentials…

   [](https://thailandbusinessnews.net/press-release/quantinuum-to-participate-in-the-piper-sandler-5th-annual-growth-frontiers-conference/) ## Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference

  BROOMFIELD, Colo., Sept. 12, 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT)…
<!-- Performance optimized by Docket Cache: https://wordpress.org/plugins/docket-cache -->
